Figure 2 | British Journal of Cancer

Figure 2

From: MicroRNA-206 expression levels correlate with clinical behaviour of rhabdomyosarcomas

Figure 2

Kaplan–Meier plots for overall survival with (A) miR-206 expression (B) miR-1 expression in all RMS samples and (C) miR-206 within fusion gene-negative patients and (D) miR-206 within fusion gene-positive patients. Expression levels within the first quartile was considered ‘low’, ‘med’ when expression was between the second and third quartile and ‘high’ when within the top quartile. P-values were obtained using log-rank test.

Back to article page